Clinical Trial Update: Dopaminergic Loss and Pain in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining dopaminergic loss and pain in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Parkinson Disease

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Parkinson's Disease, Pain | Phase 2 | Status: COMPLETED